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Background: Discordance between dialysis registry and death certificate reported death has been demonstrated.
Since cause of death is measured using registry data in dialysis patients and death certificate data in the general
population, comparisons of cause of death proportions between dialysis patients and the general population may
be biased. Our aim was to compare the proportion of deaths attributed to cardiovascular disease (CVD),
malignancy, and infections between patients receiving dialysis and the general population using death certificates
for both, and to quantify the magnitude of discrepancy between registry and death certificate estimates in dialysis
patients.
Methods: A retrospective cohort study of 5858 patients initiating maintenance dialysis between 2001 and 2007 was
conducted. Cause of death was obtained from both registry and death certificate data for dialysis patients, and
from death certificate data for the general population.
Results: Compared to the general population, use of death certificate data in dialysis patients resulted in smaller
differences in the proportion of deaths attributed to CVD or infection than that from the registry. In the general
population, the proportion of deaths due to CVD is 29.3% for men and 28.2% for women, and the proportion of
deaths due to infection is 3.3% for men and 3.6% for women. For men, the proportion of deaths in dialysis patients
due to CVD using registry data is 41.5%, compared with a proportion of 32.1% using death certificate data. Similarly
for women, the proportion of deaths due to CVD using registry data is 35.2% and that using death certificate data
24.3%. The proportion of deaths due to infection in dialysis patients follows the same pattern: for men, the
proportion of deaths due to infection using registry data is 9.9% and that from death certificate data at 5.0%; while
for women the proportions are 11.6% and 4.8%, respectively.
Conclusions: While absolute cause-specific mortality rates did differ, evaluation of causes of death using death
certificate in dialysis patients in Quebec revealed that they do not have substantially different proportion of death
due to CVD or infections than the general population. Infections appeared to be a frequent complication leading to
death, suggesting that infections are an important target to consider for reducing mortality in dialysis populations.
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In Canada, more than 22 000 patients were receiving
chronic dialysis in 2009, increasing by nearly 20% in five
years [1]. Cardiovascular disease (CVD) is the leading
cause of mortality among dialysis patients, followed by
infections [1]. It is well-established that dialysis patients
have a higher mortality rate than the general popula-
tion (GP) [1-3], and some data suggest that they have
a higher proportion of death due to CVD than the
GP [4,5].
Understanding causes of death in a given population is
important, as this data may guide prevention efforts,
patient management, and clinical or research resources
allocation. Many countries, including Canada, rely on
registry data to produce estimates of causes of death for
their dialysis population. In the GP, death certificates are
considered the best practical source of truth at a popula-
tion level. Since cause of death is measured using regis-
try data in dialysis patients and death certificates in the
GP, comparisons of cause of death proportions between
dialysis patients and the GP may be biased. Reports
comparing death certificates with dialysis registry data
have demonstrated poor cause of death concordance
[6,7]. However, the quantification of the difference rela-
tive to GP estimates has not been undertaken. Using a
single source of truth, such as death certificates, through
linkage of databases may produce more reliable esti-
mates and may drive better clinical, research and admin-
istrative decisions.
Interestingly, while many CVD-oriented interventions
such as use of statins [8,9] or angiotensin converting en-
zyme inhibitors [10] have resulted in some improvement
in outcomes (such as reduction in atherosclerotic
events), none have been demonstrated to lower mortality
in the dialysis population. While pathogenic processes
for CVD are probably different in the dialysis population
compared to the GP, the inability of large studies to
demonstrate improved survival, may suggest that atten-
tion to CVD deaths alone is insufficient to reduce mor-
tality. Attention to other important contributors, such as




Population included All chronic dialysis patients in Canada
Filling of cause of death field Registered nurse responsible for the unit,
helped with treating physician
Cause of death coding scheme Internal coding scheme (code entered
directly on the reporting form)
Abbreviations: ICD-10, International Classification of Diseases, 10th Revision.decision-making more accurately concerning interven-
tion targets, assessment of causes of death proportions
among dialysis patients should be ascertained using the
same source of truth as in the GP. Our aim was to com-
pare the proportion of deaths attributed to CVD, malig-
nancy, and infections between patients receiving dialysis
and the GP using death certificates for both, and to
quantify the magnitude of discrepancy between registry
and death certificate estimates in dialysis patients.
Methods
Data sources and study population
Data were obtained from the national Canadian dialy-
sis registry, the Canadian Organ Replacement Register
(CORR), and the provincial health services administra-
tive databases of the province of Québec, Canada. CORR
provides descriptive statistics on dialysis incidence,
prevalence and patients’ characteristics, and its data have
been used successfully in numerous scientific publica-
tions [11-15].
All Québec residents, more than 8 million inhabitants,
are covered for their physician and hospital services by a
universal single-payer health care system (Régie de
l’assurance maladie du Québec – RAMQ). The RAMQ
physician claim databases include all visits, diagnosis
codes and procedures during in- or outpatient encoun-
ters. RAMQ also hosts the hospital discharge summary
databases. The Institut de la statistique du Québec (ISQ)
holds official governmental vital statistic databases,
which include dates and causes of death as reported on
the death certificate. Information on data sources is
summarized in Table 1.
From CORR, RAMQ and ISQ, data were obtained for
all patients initiating chronic dialysis (without a prior
kidney transplant) between January 1st, 2001 and De-
cember 31st, 2007 in the province of Québec. Patients
with less than 90 days of dialysis were excluded. The
study cohort consisted of all patients who were present
in both the CORR and RAMQ databases as incident
dialysis patients. An incident cohort was used, since
comorbidities and causes of death may highly depend onInstitut de la statistique du
Québec (ISQ)
Régie de l’assurance maladie du
Québec (RAMQ)
Provincial vital statistics Medical claims and hospital discharge
summaries database
All residents in Québec
(general population)
All residents in Québec
(general population)
Treating physician N/A
ICD-10 by trained archivists
centrally
N/A
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dialysis initiation until date of death or end of the study
period.
Mortality rates in the GP of Québec were obtained
from the ISQ website for the years 2001 to 2007 [16].Measurement of dates and causes of death
CORR data provided a date of death (month and year)
and a cause of death using an internal classification (78
elements). The cause of death is usually coded by the
registered nurse responsible in each dialysis unit.
ISQ also provided a date of death (month and year)
and a cause of death coded using the International Clas-
sification of Diseases, 10th Revision (ICD-10). Death cer-
tificates are filled by physicians and then coded by
trained archivists at ISQ. For the evaluation of dates of
death concordance, the date of death provided by
RAMQ-ISQ was considered the source of truth.
The cause of death is mandatory on the death certifi-
cate (ISQ) and includes different fields: 1) underlying
disease that eventually led to death; 2) diseases in the
pathway to death (“secondary causes”); and 3) the dis-
ease or complication that directly led to death (“direct
cause”). For example, a patient may have the following
pathway: had an acute myocardial infarction (underlying
cause), followed by a cardiogenic shock (secondary
cause), and dies after a ventilator-associated pneumonia
in the intensive care unit (direct cause).
Causes of death were classified in four mutually ex-
clusive categories: CVD (ICD-10: I00-I99), infection
(A00-B99, J10-J18), malignancy (C00-D48), and other.
Among the “other” category, kidney failure (N17-N19)
and diabetes (E10-E14) were identified using death cer-
tificate, but those categories had no code using CORR
internal scheme.Statistical analysis
Dates of death from CORR and ISQ were considered
concordant if they occurred in the same month, or in a
contiguous month. Concordance was measured using
kappa statistics.
Mortality rates were calculated by dividing the number
of deaths by the total patient-years of follow-up. 95%
confidence intervals (CI) for rates were calculated using
a Poisson distribution. Mortality rates for the GP were
indirectly standardized using the study cohort age and
sex structure. Cumulative survival function was calcu-
lated using Kaplan-Meier method.
Causes of death were considered concordant if they
fell within the same category. Two concordance analyses
were done for causes of death: 1) CORR versus ISQ
underlying cause and 2) CORR versus ISQ direct cause.
Concordance was measured by non-weighted kappastatistics for categorical variables [17], and by a Chi-
square test for proportions.
Sensitivity analyses
Some codes in CORR classification system are broad and
may include various categories: Cardiac Arrest, Cause Un-
known; Patient Refused Further Treatment; Multi System
Failure; or Other Identified Cause of Death. In the main
classification, theses codes were classified as “Other” ex-
cept Cardiac Arrest, Cause Unknown that was classified as
CVD. To test the impact of this decision on the results, a
sensitivity analysis was conducted by excluding patients
who had one of these codes. Also, because a large propor-
tion of causes of death were missing in CORR, two sensi-
tivity analyses were conducted where all missing causes
were attributed to 1) CVD or 2) other causes.
Ethical considerations
Permission was obtained to conduct this study by the
Government of Québec ethics committee (Commission
d’accès à l’information), CORR internal review commit-
tee, and Maisonneuve-Rosemont Hospital ethics com-
mittee. Informed consent was waived.
Results
As shown in Figure 1, 5997 patients were identified in
the CORR cohort and 6567 patients in the RAMQ co-
hort. After merging both cohorts, 5858 patients re-
mained in the study cohort. Median age was 68 years
(interquartile range: 56 – 75), 39.7% were female, and
the majority was on hemodialysis (84.2%) versus periton-
eal dialysis (15.8%) at three months of dialysis initiation.
Median follow-up time was 2.0 years (1.0 – 3.4) using
ISQ data.
Among study patients, 1907 deaths were identified
using CORR data, while 2074 were identified using ISQ
data. In total, 96.4% of patients had a concordant death
status: 3778 were still alive at the end of the study
according to both data sources and 1872 had a concor-
dant date of death (same or contiguous month). The
remaining patients with non-concordant death status
were distributed as follow: 6 were still alive in ISQ but
deceased in CORR, 29 had a non-concordant date of
death (by a median absolute difference of 120 days), and
173 patients were still alive in CORR but deceased in
ISQ. Kappa statistics for concordance between dates of
death was excellent: 0.92 (95% CI: 0.91, 0.93).
All-cause and CVD mortality rates
All-cause mortality and CVD rates for the dialysis co-
hort (using CORR or ISQ dates of death) and GP are
presented in Figures 2 and 3. Mortality rates were con-
siderably higher in the dialysis population than in the
GP. Mortality rate using CORR was lower when using
Patients included in RAMQ 
cohort (n=6567) 
Patients included in CORR 
cohort (n=5997) 
Excluded (n=139) 
 No service in RAMQ (n=4) 
 Excluded using RAMQ data (n=135) 
- Kidney transplant prior to 
chronic dialysis (n=30) 
- Less than 3 months of follow-
up (n=45) 
- Not on maintenance dialysis at 
3 months (n=42) 
- Chronic dialysis before Jan 1, 
2001 (n=18) 
Excluded (n=709) 
 Not registered in CORR (n=593) 
 Excluded using CORR data (n=116) 
- Kidney transplant prior to 
chronic dialysis (n=40) 
- Chronic dialysis before Jan 1, 
2001 (n=19) 
- Less than 3 months of follow-
up (n=57) 
Patients included in both cohorts 
(n=5858) 
Figure 1 Derivation of dialysis cohorts. Despite meeting all inclusion criteria using RAMQ data, some RAMQ cohort patients were excluded
because they were not registered in CORR (n=593) or had been excluded using CORR data (n=116). Similarly, some patients were excluded from
CORR because they had no service in RAMQ (n=4) or were excluded based on RAMQ data (n=135).
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of death also influenced the cumulative survival func-
tion, as shown in the Kaplan-Meier curve (Figure 4).
CVD mortality rates were lower when using CORR data
than using ISQ data, but the gap appeared smaller than
with all-cause mortality.
Causes of death distribution and concordance
Cause of death was missing or unknown in 25.6% of pa-
tients with a reported date of death in CORR, while this
proportion was only 1.8% in ISQ. Distributions of causes
for patients receiving dialysis and GP are presented in
Table 2. Proportions of death attributed to either CVD
or infections were higher using registry data than using
underlying cause from death certificates. However, pro-






Figure 2 All-cause mortality rates for patients receiving dialysis (using
general population are age- and sex-adjusted to the study population. Erro
HD, hemodialysis; PD, peritoneal dialysis.registry data and direct cause of death from death cer-
tificates. In comparison to the GP, use of death cer-
tificate data (underlying cause) resulted in a more
conservative discrepancy in CVD deaths between dialysis
and GP groups: e.g. in men, the difference in percentage
points was reduced from 12% (41.5%-29.3%) to 3%
(32.1%-29.3%), and similarly in women it was reduced
from 7% (35.2%-28.2%) to −4% (24.3%-28.2%). Differ-
ences in percentage points for infections were also re-
duced to 1.7% (5.0%-3.3%) for men and 1.2% (4.8%-3.6%)
for women when using death certificate data (underlying
cause).
Using the underlying cause of death, 51.4% of patients
who had a cause of death reported in both CORR and
ISQ had congruent death categories (Table 3). Kappa





CORR versus ISQ data) and general population. Rates for the
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Figure 3 Cardiovascular-related mortality rates for patients receiving dialysis (using CORR versus ISQ data) and general population.
Rates for the general population are age- and sex-adjusted to the study population. Error bars represent 95% confidence interval of the rates.
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ses of death between categories was highly significant
(p<0.001), suggesting that the concordance in causes of
death between CORR and ISQ data did not occur by
chance. Concordance for causes of death between CORR
and ISQ improved when the direct cause of death was
used (Table 4). Percent agreement increased to 57.9%
and kappa statistic remained fair at 0.36 (0.33, 0.40).
Among the 173 patients who were considered still alive
in CORR but deceased in ISQ, 17.3% of deaths were at-



























Figure 4 Unadjusted Kaplan-Meier survival curve for all dialysis patie
initiation and the Kaplan-Meier plot was truncated when the number of pato infection, 22.0% to malignancy, 56.6% to other causes,
and 1.7% were missing.
Sensitivity analyses
Removing codes possibly overlapping multiple categories
(see Methods) did not improve concordance (kappa: 0.31
with underlying and 0.35 with direct cause). Reclassify-
ing missing cause of death in CORR as CVD (kappa:
0.20 with underlying and 0.26 with direct cause) or other
causes (kappa: 0.22 with underlying and 0.30 with direct
cause) led to slightly worse results.. CORR
. RAMQ  ISQ
3 4 5





nts using CORR or ISQ data. Note: Time starts at 90 day after dialysis
tients at risk reached 10% of baseline.
Table 2 Distribution of causes of death according to CORR and ISQ for patients receiving dialysis and for the general
population
Causes of death CORR ISQ – Underlying cause ISQ – Direct cause General population*
N % N % N % %
Both sex
Cardiovascular 555 39.1% 592 29.1% 557 27.4% 28.9%
Infection 149 10.5% 101 5.0% 222 10.9% 3.4%
Malignancy 149 10.5% 284 14.0% 153 7.5% 36.1%
Other 565 39.9% 1059 52.0% 1104 54.2% 31.6%
Diabetes N/A 339 16.7% 14 0.7% 3.3%
Kidney failure N/A 400 19.6% 576 28.3% 1.8%
Female
Cardiovascular 189 35.2% 191 24.3% 184 23.4% 28.2%
Infection 62 11.6% 38 4.8% 92 11.7% 3.6%
Malignancy 59 11.0% 107 13.6% 59 7.5% 34.9%
Other 227 42.3% 449 57.2% 450 57.3% 33.3%
Diabetes N/A 146 18.6% 7 0.9% 3.4%
Kidney failure N/A 161 20.5% 232 29.6% 1.6%
Male
Cardiovascular 366 41.5% 401 32.1% 373 29.8% 29.3%
Infection 87 9.9% 63 5.0% 130 10.4% 3.3%
Malignancy 90 10.2% 177 14.2% 94 7.5% 36.7%
Other 338 38.4% 610 48.8% 654 52.3% 30.7%
Diabetes N/A 193 15.4% 7 0.6% 3.2%
Kidney failure N/A 239 19.1% 344 27.5% 1.8%
Note: Cause of death was missing or unknown in 489 patients (25.6%) in CORR and 38 patients (1.8%) in ISQ. Kidney failure and diabetes are not defined in CORR
internal coding scheme and could not be reported.
*General population of Quebec, Canada, 2001 to 2007, indirectly standardized.
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This study reports on the comparison of cause of death
proportions between dialysis patients and the GP. It
demonstrated poor concordance between registry data
and death certificates. This discrepancy between registry
data and death certificates led to different conclusions
when proportions of death attributed to CVD were com-








406 (29.3%) 72 (5.2CORR showed a higher CVD death proportion among
dialysis patients, ISQ showed almost no difference com-
pared to the GP. While the proportion of deaths due to
infection was also higher among dialysis patients using
CORR data than when compared to underlying cause of
death, proportions estimated from direct cause of death
in the death certificate showed that they remained an
important complication of disease (biological mechanism)both CORR and ISQ using the underlying cause of death
- Underlying cause
on Malignancy Other
13 274 543 (39.1%)
15 74 148 (10.7%)
106 25 148 (10.7%)
67 336 549 (39.6%)
%) 201 (14.5%) 709 (51.1%) 1388 (100%)
Table 4 Causes of death for patients with a cause of death in both CORR and ISQ using the direct cause of death in
ISQ
ISQ -- Direct cause
Cardiovascular Infection Malignancy Other
CORR Cardiovascular 286 32 5 220 543 (39.1%)
Infection 14 69 3 62 148 (10.7%)
Malignancy 10 12 68 58 148 (10.7%)
Other 85 44 39 381 549 (39.6%)
395 (28.5%) 157 (11.3%) 115 (8.3%) 721 (52.0%) 1388 (100%)
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more than a quarter of deaths in CORR, greatly dimi-
nishing its usefulness.
Many countries and regions collect and report mor-
tality data from renal dialysis programs using registries.
Examples include the United States Renal Data Sys-
tem (USRDS), United Kingdom Renal Registry (UKRR),
European Dialysis and Transplant Association/European
Renal Association (EDTA/ERA), and Australia and New
Zealand Dialysis and Transplant Registry (ANZDATA)
[18]. Most dialysis registries use an internal coding sys-
tem to classify cause of death instead of ICD-10 [2,19].
Reports of distribution of causes of death for patients on
dialysis vary between countries, influenced in part by dif-
ferent age distributions and case-mix among popula-
tions. CVD remains the most frequent cause in all (31 to
55% of deaths), followed in most countries by infections
(11 to 18%), and malignancies (4 to 13%) [19-21]. Of
note, distribution of causes of death reported for the GP
are age and sex adjusted to the dialysis cohort. There-
fore, causes of death associated with older age have a
higher weight, explaining why malignancies are the lead-
ing cause of death at 36.1% in the GP.
Our finding of only fair concordance of cause of death
between ISQ and CORR is consistent with results from
previous reports using USRDS and ANZDATA (overall
kappa from 0.22 to 0.24) [6,7]. One may hypothesize
that, in most of those dialysis populations, reported
CVD death proportions are likely higher than what
would have been reported using DC. To our knowledge,
no study has quantitatively evaluated the proportion of
deaths attributable to different causes in comparison to
GP, using the same source of information (DC) for both
populations.
In the UKRR, part of their data (England and Wales)
is linked with national vital statistics [18,22]. In USRDS,
only 1% of deaths are ascertained through national vital
statistics [2]. However, reporting death to USRDS is
mandatory. CORR is a voluntary registry with no linkage
to vital statistic registries. This may account for some of
the discrepancies observed in our analysis. Given that in-
formation from registries (such as cause of death) isprecious to guide policy, planning and resources we in-
sist that better identification of true causes of death in
dialysis populations is important, and that we do have
an opportunity to remedy to the current situation in
Canada.
While validity of death occurrence and its date is fairly
high in vital statistic registries such as ISQ [23], mis-
classification of the cause of death is known to occur
[7,24,25]. Of note, neither CORR nor ISQ is a true gold
standard for cause of death, which will always be subject
to some misclassification. DC, obtained from the ISQ
data, constitute the most valid practical tool available to
determine the cause of death on a provincial level. This
study did not evaluate differences between registry and
death certificates coding variation by country. However,
as mentioned earlier poor concordance was reported in
two other countries, so it is likely that this is a true
phenomenon.
Conclusion
In conclusion, evaluation of causes of death using DC in
dialysis patients in Quebec revealed that they do not
have substantially different proportion of death due to
CVD or infections than the GP. However, infections
appeared to be a frequent complication or biological
mechanism leading to death. While all-cause and CVD
absolute mortality rates remain many times higher
among dialysis patients compared to the GP (no matter
which source of data), use of registry data alone would
lead health care practitioners and researchers to con-
clude that there is more than 10 percentage points
higher proportion of deaths attributed to CVD in dialysis
populations than is really the case. In an era of increas-
ing need for accuracy in medical records, we believe that
validation of registry data, or development of better link-
age with vital statistics in Canada, should be undertaken
for dialysis populations. In this way, we may be able to
better establish priorities for prevention and therapeutic
efforts, or clinical and research resources allocation. While
CVD remains an important issue among dialysis patients,
infections appear to be an important target to consider as
a means to reducing mortality in that population.
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